{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T15:59:25Z","timestamp":1770825565922,"version":"3.50.1"},"reference-count":51,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T00:00:00Z","timestamp":1692748800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Medical University of Silesia in Katowice"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>The effect of metformin on prolactin concentration seems to be sex-dependent. The aim of this study was to determine whether the androgen status modulates the impact of metformin on plasma prolactin levels in women. This study included two matched groups of prediabetic women with hyperprolactinemia: 25 with PCOS and 25 control subjects with androgen levels within the reference range and with normal ovarian morphology. Glucose homeostasis markers, prolactin, the remaining anterior pituitary hormones, sex hormones, SHBG and IGF-1 were determined before and after six months of metformin treatment. At baseline, both groups differed in LH, LH\/FSH ratio, testosterone, FAI, DHEA-S, androstenedione and estradiol. Although metformin improved insulin sensitivity and increased SHBG in both study groups, these effects were more pronounced in control subjects than in women with PCOS. In control subjects, the drug decreased total and monomeric prolactin and increased LH. In women with PCOS, metformin reduced LH, LH\/FSH ratio, testosterone and FAI. In the control group, the impact on total and monomeric prolactin positively correlated with their baseline levels and with the degree of improvement in insulin sensitivity, as well as negatively correlated with testosterone and FAI. In women with PCOS, treatment-induced changes in testosterone and FAI positively correlated with the changes in LH and LH\/FSH ratio. The obtained results suggest that the prolactin-lowering properties of metformin are less pronounced in women with coexisting PCOS than in women with elevated prolactin levels, probably owing to the increased production of endogenous testosterone.<\/jats:p>","DOI":"10.3390\/jcm12175474","type":"journal-article","created":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T10:23:40Z","timestamp":1692872620000},"page":"5474","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Impaired Prolactin-Lowering Effects of Metformin in Women with Polycystic Ovary Syndrome"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5454-2620","authenticated-orcid":false,"given":"Robert","family":"Krysiak","sequence":"first","affiliation":[{"name":"Department of Internal Medicine and Clinical Pharmacology, Medical University of Silesia, Medyk\u00f3w 18, 40-752 Katowice, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karolina","family":"Kowalcze","sequence":"additional","affiliation":[{"name":"Department of Pediatrics in Bytom, Faculty of Health Sciences in Katowice, Medical University of Silesia, Stefana Batorego 15, 41-902 Bytom, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Witold","family":"Szkr\u00f3bka","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Clinical Pharmacology, Medical University of Silesia, Medyk\u00f3w 18, 40-752 Katowice, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7228-2906","authenticated-orcid":false,"given":"Bogus\u0142aw","family":"Okopie\u0144","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Clinical Pharmacology, Medical University of Silesia, Medyk\u00f3w 18, 40-752 Katowice, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,8,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1080\/17446651.2018.1434412","article-title":"The effects of hyperprolactinemia and its control on metabolic diseases","volume":"13","author":"Auriemma","year":"2018","journal-title":"Expert Rev. Endocrinol. Metab."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"482","DOI":"10.5603\/EP.2017.0050","article-title":"Metformin\u2014A new old drug","volume":"68","author":"Marek","year":"2017","journal-title":"Endokrynol. Pol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1176\/appi.ajp.2012.11091432","article-title":"Metformin for treatment of antipsychotic-induced amenorrhea and weight gain in women with worst-episode schizophrenia: A double-blind, randomized, placebo-controlled study","volume":"169","author":"Wu","year":"2012","journal-title":"Am. J. Psychiatry"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1177\/0269881117699630","article-title":"Adjunctive metformin for antipsychotic-related hyperprolactinemia: A meta-analysis of randomized controlled trials","volume":"31","author":"Zheng","year":"2017","journal-title":"J. Psychopharmacol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.psychres.2016.01.031","article-title":"Adjunctive metformin for antipsychotic-induced hyperprolactinemia: A systematic review","volume":"237","author":"Bo","year":"2016","journal-title":"Psychiatry Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ejim.2016.01.015","article-title":"The effect of metformin on prolactin levels in patients with drug-induced hyperprolactinemia","volume":"30","author":"Krysiak","year":"2016","journal-title":"Eur. J. Intern. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s12020-014-0428-2","article-title":"The effect of short-term metformin treatment on plasma prolactin levels in bromocriptine-treated patients with hyperprolactinaemia and impaired glucose tolerance: A pilot study","volume":"49","author":"Krysiak","year":"2015","journal-title":"Endocrine"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1055\/s-0042-123041","article-title":"Alternative treatment strategies in women poorly tolerating moderate doses of bromocriptine","volume":"125","author":"Krysiak","year":"2017","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1159\/000514591","article-title":"Prolactin response to metformin in cabergoline-resistant prolactinomas: A pilot study","volume":"112","author":"Portari","year":"2022","journal-title":"Neuroendocrinology"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1055\/s-0042-117718","article-title":"A neutral effect of metformin treatment on macroprolactin content in women with macroprolactinemia","volume":"125","author":"Krysiak","year":"2016","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"ref_11","first-page":"342","article-title":"Sex-dependent effect of metformin on serum prolactin levels in hyperprolactinemic patients with type 2 diabetes: A pilot study","volume":"26","author":"Krysiak","year":"2018","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1159\/000499470","article-title":"Dopamine agonists: From the 1970s to today","volume":"109","author":"Auriemma","year":"2019","journal-title":"Neuroendocrinology"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s12020-022-03145-1","article-title":"Cardiometabolic profile of young women with hypoprolactinemia","volume":"78","author":"Krysiak","year":"2022","journal-title":"Endocrine"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/cen.14283","article-title":"Sexual function and depressive symptoms in young women with hyperprolactinemia","volume":"93","author":"Krysiak","year":"2020","journal-title":"Clin. Endocrinol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nrendo.2018.24","article-title":"Polycystic ovary syndrome: Definition, aetiology, diagnosis and treatment","volume":"14","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e1071","DOI":"10.1210\/clinem\/dgaa839","article-title":"Update on PCOS: Consequences, challenges, and guiding treatment","volume":"106","author":"Hoeger","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1179558119871921","DOI":"10.1177\/1179558119871921","article-title":"PCOS and hyperprolactinemia: What do we know in 2019?","volume":"13","author":"Delcour","year":"2019","journal-title":"Clin. Med. Insights Reprod. Health"},{"key":"ref_18","first-page":"93","article-title":"Cabergoline plus metformin therapy effects on menstrual irregularity and androgen system in polycystic ovary syndrome women with hyperprolactinemia","volume":"13","author":"Ghaneei","year":"2015","journal-title":"Iran. J. Reprod. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s13224-017-1022-3","article-title":"Efficacy of combined cabergoline and metformin compared to metformin alone on cycle regularity in patients with polycystic ovarian disease with hyperprolactinemia: A randomized clinical trial","volume":"67","author":"Elsersy","year":"2017","journal-title":"J. Obstet. Gynecol. India"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1055\/a-0921-6420","article-title":"The impact of ethinyl estradiol on metformin action on prolactin levels in women with hyperprolactinemia","volume":"129","author":"Krysiak","year":"2021","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"ref_21","first-page":"1430","article-title":"The impact of metformin on prolactin levels in postmenopausal women","volume":"46","author":"Krysiak","year":"2021","journal-title":"J. Clin. Pharm. Ther."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/bcpt.13307","article-title":"Endogenous testosterone determines metformin action on prolactin levels in hyperprolactinaemic men: A pilot study","volume":"126","author":"Krysiak","year":"2020","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.pharep.2015.02.001","article-title":"The effect of oral contraception on macroprolactin levels in women with macroprolactinemia: A pilot study","volume":"67","author":"Krysiak","year":"2015","journal-title":"Pharmacol. Rep."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1055\/a-0584-0006","article-title":"The effect of metformin on serum gonadotropin levels in postmenopausal women with diabetes and prediabetes: A pilot study","volume":"126","author":"Krysiak","year":"2018","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"E143","DOI":"10.1210\/jc.2013-2965","article-title":"Effects of treatment with metformin on TSH levels: A meta-analysis of literature studies","volume":"99","author":"Lupoli","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1258\/0004563053857969","article-title":"Macroprolactin; high molecular mass forms of circulating prolactin","volume":"42","author":"John","year":"2005","journal-title":"Ann. Clin. Biochem."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1159\/000175841","article-title":"Laboratory measurement of testosterone","volume":"37","author":"Diver","year":"2009","journal-title":"Front. Horm. Res."},{"key":"ref_28","first-page":"79","article-title":"Male equivalent polycystic ovarian syndrome: Hormonal, metabolic, and clinical aspects","volume":"14","author":"Ciotta","year":"2020","journal-title":"Int. J. Fertil. Steril."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1002\/jcph.2088","article-title":"Pituitary effects of metformin in men with early-onset androgenic alopecia","volume":"62","author":"Krysiak","year":"2022","journal-title":"J. Clin. Pharmacol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0889-8529(02)00087-7","article-title":"The role of estrogens in men and androgens in women","volume":"32","author":"Khosla","year":"2003","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"160","DOI":"10.4103\/2230-8210.146874","article-title":"Assessment of insulin sensitivity\/resistance","volume":"19","author":"Gutch","year":"2015","journal-title":"Indian J. Endocrinol. Metab."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/BF02739938","article-title":"Pituitary sex steroid receptors: Localization and function","volume":"8","author":"Stefaneanu","year":"1997","journal-title":"Endocr. Pathol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1095\/biolreprod.110.087023","article-title":"Metformin decreases GnRH- and activin-induced gonadotropin secretion in rat pituitary cells: Potential involvement of adenosine 5\u2032 monophosphate-activated protein kinase (PRKA)","volume":"84","author":"Tosca","year":"2011","journal-title":"Biol. Reprod."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1210\/endrev\/bnaa023","article-title":"Cellular and molecular mechanisms of metformin action","volume":"42","author":"LaMoia","year":"2021","journal-title":"Endocr. Rev."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s10787-022-00980-6","article-title":"The role of AMPK-dependent pathways in cellular and molecular mechanisms of metformin: A new perspective for treatment and prevention of diseases","volume":"30","author":"Hasanvand","year":"2022","journal-title":"Inflammopharmacology"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"105752","DOI":"10.1016\/j.jsbmb.2020.105752","article-title":"Involvement of endogenous testosterone in hepatic steatosis in women with polycystic ovarian syndrome","volume":"204","author":"Li","year":"2020","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1016\/j.neuroimage.2008.10.020","article-title":"The distribution of D2\/D3 receptor binding in the adolescent rhesus monkey using small animal PET imaging","volume":"44","author":"Christian","year":"2009","journal-title":"Neuroimage"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1677\/joe.1.05844","article-title":"Insulin sensitizing drugs increase the endogenous dopaminergic tone in obese insulin-resistant women with polycystic ovary syndrome","volume":"184","author":"Cardoza","year":"2005","journal-title":"J. Endocrinol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000125846","article-title":"Role of testosterone in the regulation of tuberoinfundibular dopaminergic neurons in the male rat","volume":"54","author":"Toney","year":"1991","journal-title":"Neuroendocrinology"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/jcph.373","article-title":"The effect of metformin on the hypothalamic-pituitary-thyroid axis in women with polycystic ovary syndrome and subclinical hypothyroidism","volume":"55","author":"Krysiak","year":"2015","journal-title":"J. Clin. Pharmacol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"611","DOI":"10.2169\/internalmedicine.48.1829","article-title":"Polycystic ovary syndrome and prolactinoma association","volume":"48","author":"Yavasoglu","year":"2009","journal-title":"Intern. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1210\/jcem-62-2-348","article-title":"Inhibitory effect of bromocriptine treatment on luteinizing hormone secretion in polycystic ovary syndrome","volume":"62","author":"Falaschi","year":"1986","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1093\/humrep\/16.11.2263","article-title":"Cabergoline influences ovarian stimulation in hyperprolactinaemic patients with polycystic ovary syndrome","volume":"16","author":"Papaleo","year":"2001","journal-title":"Hum. Reprod."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1210\/endo-108-3-1095","article-title":"Relationship of polycystic ovary induction to prolactin secretion: Prevention of cyst formation by bromocriptine in the rat","volume":"108","author":"Copmann","year":"1981","journal-title":"Endocrinology"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"180","DOI":"10.17305\/bjbms.2013.2359","article-title":"Evaluation of endocrine changes in women with the polycystic ovary syndrome during metformin treatment","volume":"13","year":"2013","journal-title":"Bosn. J. Basic Med. Sci."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ijgo.2004.08.015","article-title":"Metformin therapy in women with polycystic ovary syndrome","volume":"87","author":"Aruna","year":"2004","journal-title":"Int. J. Gynecol. Obstet."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/B978-0-444-59602-4.00013-7","article-title":"Hyperprolactinemia and prolactinoma","volume":"124","author":"Romijn","year":"2014","journal-title":"Handb. Clin. Neurol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0015-0282(02)04925-7","article-title":"Metformin has direct effects on human ovarian steroidogenesis","volume":"79","author":"Mansfield","year":"2003","journal-title":"Fertil. Steril."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s10549-010-0834-y","article-title":"Metformin inhibits aromatase expression in human breast adipose stromal cells via stimulation of AMP-activated protein kinase","volume":"123","author":"Brown","year":"2010","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"4794","DOI":"10.1210\/en.2009-0540","article-title":"Metformin inhibits aromatase via an extracellular signal-regulated kinase-mediated pathway","volume":"150","author":"Rice","year":"2009","journal-title":"Endocrinology"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1210\/jc.2012-3780","article-title":"Challenges to the measurement of estradiol: An endocrine society position statement","volume":"98","author":"Rosner","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/12\/17\/5474\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:41:04Z","timestamp":1760128864000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/12\/17\/5474"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,23]]},"references-count":51,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2023,9]]}},"alternative-id":["jcm12175474"],"URL":"https:\/\/doi.org\/10.3390\/jcm12175474","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,23]]}}}